Erika Ryan
Psychiatric/Mental Health · Springfield, MANPI 1356698542
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 96.4% of the total across 407 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 16 manufacturers reported payments, led by AbbVie at 30.1% of the total. 2025 is the largest year on record at $3,730, 2.1 times the $1,812 reported in 2021. Among psychiatric/mental health clinicians in MA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 407 payments — averaging $25.02 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$3K
- Neurocrine Biosciences, Inc.$1K
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$1K
- Teva Pharmaceuticals USA, Inc.$999
- Otsuka America Pharmaceutical, Inc.$690
- Johnson & Johnson$510
- plus $2K from 10 others
What the payments were for
- Food & beverage$9,81296%
- Education$3714%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 123 | $3,067 |
| Neurocrine Biosciences, Inc. | 43 | $1,443 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 50 | $1,225 |
| Teva Pharmaceuticals USA, Inc. | 36 | $999 |
| Otsuka America Pharmaceutical, Inc. | 30 | $690 |
| Johnson & Johnson | 15 | $510 |
| Vanda Pharmaceuticals Inc. | 32 | $496 |
| Sunovion Pharmaceuticals Inc. | 25 | $465 |
| E.r. Squibb & Sons, L.L.C. | 15 | $385 |
| Alkermes, Inc. | 16 | $347 |
| Lundbeck LLC | 11 | $272 |
| Axsome Therapeutics, Inc. | 5 | $146 |
| Supernus Pharmaceuticals, Inc. | 3 | $70 |
| Corium, LLC | 1 | $28 |
| Indivior Inc. | 1 | $25 |
| Eisai Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- VRAYLAR$603
- INGREZZA$236
- CAPLYTA$222
- INVEGA SUSTENNA$219
- AUSTEDO$125
- UZEDY$113
- INVEGA TRINZA$112
- INVEGA$112
- SPRAVATO$112
- Fanapt$110
How this compares
$10,183 in reported general payments places this provider in the 95th percentile of 1,284 psychiatric/mental health providers in Massachusetts.
See all psychiatric/mental health providers in Massachusetts →
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Quetiapine Fumarate | 22 | $370 |
| Sertraline Hcl | 21 | $344 |
| Trazodone Hcl | 14 | $149 |
| Prazosin Hcl | 11 | $144 |
Paid to pharmacies, not to this prescriber.
Other psychiatric/mental health in Springfield
- Nicola WilliamsSpringfield$7K
- Brianne LienkampMarion$121K
- Ashley BakerQuincy$54K
- Brian BanksPembroke$47K
- Anne-Margaret BotelhoMattapoisett$46K
- Matthew PeculisWalpole$41K
- Sherrie UrenaWorcester$21K
- Irina DauphineeHanover$18K
- Schree PettigrewNew Bedford$18K
- Sherryl RosenLynn$16K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.